The prevalence of NAFLD and NAFLD having elevation of ALT was significantly progressively greater in subjects with Non-MS, Pre-MS, and MS (p <0.001, respectively). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.